GH Research (GHRS) Other Non Operating Income (2021 - 2025)

GH Research's (GHRS) quarterly Other Non Operating Income came in at $2.6 million in Q4 2025, down 37.71% year-on-year from $4.1 million in Q4 2024, and up 1.38% quarter-over-quarter from $2.5 million in Q3 2025.

GH Research (GHRS) Other Non Operating Income (2021 - 2025) Analysis & Trends

GH Research's Other Non Operating Income history runs 5 years deep, the most recent figure standing at $2.6 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 37.71% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $12.5 million, a 9.77% increase from a year earlier, with the FY2025 full-year figure at $12.5 million, up 9.77% from the prior year.
  • Other Non Operating Income climbed to $2.6 million in Q4 2025 per GHRS's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $7.1 million in Q2 2022 and bottomed at -$8.3 million in Q4 2023.
  • The 5-year median for Other Non Operating Income is $2.5 million (2021), against an average of $1.7 million.
  • Biggest YoY gain for Other Non Operating Income was 25022.22% in 2022; the steepest drop was 428.54% in 2022.
  • Year by year, Other Non Operating Income stood at $2.5 million in 2021, then tumbled by 428.54% to -$8.3 million in 2022, then fell by 0.43% to -$8.3 million in 2023, then surged by 149.62% to $4.1 million in 2024, then tumbled by 37.71% to $2.6 million in 2025.
  • Per Business Quant, the three latest GHRS Other Non Operating Income figures stand at $2.6 million (Q4 2025), $2.5 million (Q3 2025), and $5.4 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 GH Research 1.69 Bn 1.69 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.58 Mn
Sep 30, 2025 2.55 Mn
Jun 30, 2025 5.42 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 4.14 Mn
Sep 30, 2024 507,000.00
Jun 30, 2024 2.84 Mn
Mar 31, 2024 3.86 Mn
Dec 31, 2023 -8.35 Mn
Sep 30, 2023 4.07 Mn
Jun 30, 2023 2.20 Mn
Mar 31, 2023 -1.64 Mn
Dec 31, 2022 -8.31 Mn
Sep 30, 2022 6.19 Mn
Jun 30, 2022 7.08 Mn
Mar 31, 2022 2.24 Mn
Dec 31, 2021 2.53 Mn
Sep 30, 2021 2.83 Mn
Jun 30, 2021 554,000.00
Mar 31, 2021 -9,000.00